Lanfan Medical: On March 23, Liu Wenjing, Cui Yuntao, Zhao Min, and Wang Ziyi increased their holdings by a total of 145,200 shares.

According to Securities Star, based on market public information, announcements from listed companies, and data disclosed by exchanges on March 24, the latest changes in shareholdings of directors, supervisors, and senior executives of Lanfang Medical (002382) are as follows: On March 23, 2026, the company’s director Liu Wenjing, executives Cui Yuntao, director Zhao Min, and secretary Wang Ziyi collectively increased their holdings by 145,200 shares, accounting for 0.0144% of the company’s total share capital. During the change period, the company’s stock price fell by 3.21%, closing at 7.55 yuan on March 23.

The details of the increase and decrease in shareholdings of Lanfang Medical’s directors, supervisors, and core technical personnel in the past six months are as follows:

The list of Lanfang Medical executives and their latest shareholdings is as follows:

Margin financing data shows that the net inflow of financing for this stock in the past five days is 24.4864 million, with the financing balance increasing; the net outflow of the margin is 94,000.0, with the margin balance decreasing.

In the last 90 days, one institution has given a rating for this stock, with one buy rating.

The above content is compiled by Securities Star based on public information and generated by AI algorithms (Internet Information Office registration number 310104345710301240019), and does not constitute investment advice.